The Influence of Polysaccharides from Sea Algae on the Pathogenetic Targets of <i>Helicobacter Pylori</i> — a New Direction in Therapy and Prevention of Infection
According to epidemiological data, 60% of the world's population suffers from Helicobacter pyloriinfection. The multicomponent treatment used in 18–20% of cases does not allow eradication of H.pylori. In addition, reinfection with H.pylori occurs in the majority of treated patients in 3–5 years...
Saved in:
| Main Authors: | N. N. Besednova, T. A. Kuznetsova, T. S. Zaporozhets, S. P. Kryzhanovsky, A. K. Gazha, E. Yu. Dobryakov, T. N. Zvyagintseva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/709 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Marine Algae Polysaccharides - a Promising Means of Pathogenetic Therapy of Infectious Diarrhea
by: N. N. Besednova, et al.
Published: (2020-11-01) -
Rapid and Efficient Screening of <i>Helicobacter pylori</i> in Gastric Samples Stained with Warthin–Starry Using Deep Learning
by: José Aneiros-Fernández, et al.
Published: (2025-04-01) -
<i>Helicobacter pylori</i> Vaccine: Mechanism of Pathogenesis, Immune Evasion and Analysis of Vaccine Types
by: Jingwen Gong, et al.
Published: (2025-05-01) -
Hepatoprotective Effects of Extracts and Polysaccharides from Seaweed
by: N. N. Besednova, et al.
Published: (2020-05-01) -
Pathogenetic Targets of Sea Algae Polysaccharides in Non-Alcoholic Fatty Liver Disease
by: S. P. Kryzhanovsky, et al.
Published: (2024-11-01)